Cardiff Oncology Inc (CRDF)
3.63
-0.11
(-2.94%)
USD |
NASDAQ |
May 17, 16:00
3.64
+0.01
(+0.28%)
After-Hours: 20:00
Cardiff Oncology Cash and Short Term Investments (Quarterly): 67.19M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 67.19M |
December 31, 2023 | 74.82M |
September 30, 2023 | 81.36M |
June 30, 2023 | 89.43M |
March 31, 2023 | 96.97M |
December 31, 2022 | 105.27M |
September 30, 2022 | 114.30M |
June 30, 2022 | 122.01M |
March 31, 2022 | 129.36M |
December 31, 2021 | 140.82M |
September 30, 2021 | 134.05M |
June 30, 2021 | 140.05M |
March 31, 2021 | 125.58M |
December 31, 2020 | 130.98M |
September 30, 2020 | 36.41M |
June 30, 2020 | 27.75M |
March 31, 2020 | 9.277M |
December 31, 2019 | 10.20M |
September 30, 2019 | 9.032M |
June 30, 2019 | 10.79M |
March 31, 2019 | 11.33M |
December 31, 2018 | 11.45M |
September 30, 2018 | 15.07M |
June 30, 2018 | 18.52M |
March 31, 2018 | 6.657M |
Date | Value |
---|---|
December 31, 2017 | 8.226M |
September 30, 2017 | 7.434M |
June 30, 2017 | 7.784M |
March 31, 2017 | 28.80M |
December 31, 2016 | 37.89M |
September 30, 2016 | 46.95M |
June 30, 2016 | 50.58M |
March 31, 2016 | 59.99M |
December 31, 2015 | 67.49M |
September 30, 2015 | 74.15M |
June 30, 2015 | 41.29M |
March 31, 2015 | 44.00M |
December 31, 2014 | 27.29M |
September 30, 2014 | 31.16M |
June 30, 2014 | 34.67M |
March 31, 2014 | 22.87M |
December 31, 2013 | 25.84M |
September 30, 2013 | 27.80M |
June 30, 2013 | 8.302M |
March 31, 2013 | 9.164M |
December 31, 2012 | 10.82M |
September 30, 2012 | 7.815M |
June 30, 2012 | 9.304M |
March 31, 2012 | 0.5868M |
December 31, 2011 | 0.7004M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
9.032M
Minimum
Sep 2019
140.82M
Maximum
Dec 2021
82.78M
Average
93.20M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
BioVie Inc | 20.23M |
Perspective Therapeutics Inc | 180.65M |
Biolase Inc | 6.393M |
Tenon Medical Inc | 2.428M |
Adial Pharmaceuticals Inc | 2.827M |